Journals / Bozok Tıp Dergisi / 2025 / Cilt: 15 Sayı: 4

Retrospective Analysis of Epistaxis Cases: The Impact of Comorbidity and Recurrence on Treatment Approaches

Epistaksis Vakalarının Retrospektif Analizi: Eşlik Eden Hastalık ve Rekürrensin Tedavi Yaklaşımları Üzerindeki Etkisi

Tuba Doğan Karataş(Sivas Cumhuriyet Üniversitesi)0000-0002-2610-6562
Ahmet Aksoy(Department of Otorhinolaryngology, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey)0000-0002-7744-8124
Barış Şapcı(Department of Otorhinolaryngology, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey)0000-0002-4404-9768
Mansur Doğan(Department of Otorhinolaryngology, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey)0000-0002-3964-9363
Pages
484–490
Publication Date
2025-12-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Careful evaluation of the patient’s medical history and comorbid conditions is essential for optimal management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim was to evaluate the etiology and treatment approach of patients who visited our clinic with nosebleeds, in accordance with the latest literature.
📊
Key Findings & Data:Material and Methods: Between January 2018 and March 2023, patients who had been diagnosed with epistaxis and either consulted the outpatient clinic of a tertiary university hospital's ear, nose, and throat department or were referred from the emergency department and had available data through the hospital's information system were retrospectively reviewed.
💡
Conclusion & Impact:Careful evaluation of the patient’s medical history and comorbid conditions is essential for optimal management.
🔬Design:Review & Systematic Survey
📍Scope:2018 Verileri
⚙️Variables:Epistaksis · nazal tampon · koterizasyon

Abstract

Objective: The aim was to evaluate the etiology and treatment approach of patients who visited our clinic with nosebleeds, in accordance with the latest literature. Material and Methods: Between January 2018 and March 2023, patients who had been diagnosed with epistaxis and either consulted the outpatient clinic of a tertiary university hospital's ear, nose, and throat department or were referred from the emergency department and had available data through the hospital's information system were retrospectively reviewed. Results: Of the 2169 patients diagnosed with epistaxis, 658 patients aged 0-95 years with no exclusion criteria were included in the study. The average age was 38.4 years, with 54% of the participants being male. The highest number of admissions occurred in February. Recurrent epistaxis was observed in 28.1% of patients, while 8.7% had a single episode, which was more common among women. Most patients presented on an outpatient basis (78.9%) and received only medical treatment (90.4%). A history of surgery was present in 3.3% of cases, mostly following septorhinoplasty. Most 2.6% of the patients who needed hospitalization had other health conditions. The recurrence rates were also higher in patients with comorbid conditions. Conclusion: Epistaxis is a common otorhinolaryngologic emergency that can usually be managed with outpatient medical treatment. However, patients with comorbidities and older age are at a higher risk for recurrence and hospitalization. Careful evaluation of the patient’s medical history and comorbid conditions is essential for optimal management.

Özet

Amaç: Kliniğimize burun kanaması nedeniyle başvuran hastaların etyolojisi ve tedavi yaklaşımı literatür eşliğinde değerlendirilmesi amaçlanmıştır. Materyal ve Metod: Ocak 2018 – Mart 2023 tarihleri arasında, üçüncü basamak üniversite hastanesi Kulak Burun Boğaz (KBB) Hastalıkları polikliniğine ayaktan başvuran ya da acil servisten yönlendirilerek tarafımıza danışılan epistaksis tanılı ve hastane bilgi sistemi verilerine ulaşılabilen hastalar retrospektif olarak incelendi. Bulgular: Epistaksis tanılı 2169 hastadan, dışlama kriterleri olmayan 0-95 yaş arasındaki 658 hasta çalışmaya dahil edildi. Hastaların yaş ortalaması 38,4 yıl olup %54’ü erkekti. En sık başvuru şubat ayında gerçekleşmiş, 28.1’inde tekrarlayan epistaksis, %8,7’sinde tek başvuru saptanmıştır. Tek başvurular kadınlarda daha fazlaydı. Hastaların çoğu ayaktan başvurmuş (78.9%) ve medikal tedavi almıştır (90.4%). Cerrahi öykü %3,3 oranında olup çoğunluğu septorinoplasti sonrasıydı. Yatarak tedavi edilen %2,6 hastanın çoğunda komorbidite bulunmaktaydı. Komorbid hastalarda rekürrens oranı da daha yüksekti. Sonuç: Epistaksis çoğunlukla ayaktan medikal tedavi ile kontrol altına alınabilen, ancak komorbiditesi olan ve ileri yaş grubundaki hastalarda rekürrens ve hospitalizasyon ihtimali artan sık bir KBB acilidir. Hastaların öykü ve ek hastalıklarının dikkatle değerlendirilmesi, uygun tedavi yaklaşımının belirlenmesinde kritik öneme sahiptir.

🔖

Cite This Article

Karataş, T. D., Aksoy, A., Şapcı, B., Doğan, M. (2025). Retrospective Analysis of Epistaxis Cases: The Impact of Comorbidity and Recurrence on Treatment Approaches. Bozok Tıp Dergisi, Cilt: 15 Sayı: 4, 484–490. https://doi.org/10.16919/bozoktip.1790913

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Erdemes S, Yükkaldıran A, Erdoğan O, Ayral M. Epistaksisle başvuran geriyatrik hastaların analizi. Van Saglik Bil Derg. 2023;16(1):14-9.
  2. Şahin G, Yücel A, Korkmaz H, Yıldız E, Demirci T, Kaya B. Epistaksis ile başvuran olgularda kanama diyatezi oranı ve pediatrik kanama skorunun tanıdaki değeri. Selcuk Tip Derg. 2021;37(2):124-9.
  3. Kucur C, Özbay İ, Aksoy S, Oğhan F, Yıldırım N. Epistaksisli hastaya klinik yaklaşım. Turk J Clin Lab. 2015;6(1):14-8.
  4. Tabassom A, C JJ. Epistaxis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www. ncbi.nlm.nih.gov/books/NBK470183/
  5. Yuca K, Eryılmaz MA, Varsak YK. Clinical evaluation of epistaxis. Selcuk Tip Derg. 2011;29(4):200-3.
  6. Kaygusuz İ, Keleş E, Karlıdağ T, Yalçın Ş, Yücel A, Akyıldız İ, et al. Hastaneye yatırılarak tedavi edilen 68 epistaksisli hastanın retrospektif analizi. Firat Tip Derg. 2004;9(3):82-5.
  7. Seikaly H. Epistaxis. N Engl J Med. 2021;384(10):944-51.
  8. Özcan C. Epistaksis. In: Koç C, editor. Kulak Burun Boğaz Hastalıkları ve Baş Boyun Cerrahisi. 2nd ed. Ankara: Güneş Tıp Kitabevi; 2013. p. 411–4.
  9. Ruhela S, Mittal HK, Bist SS, Luthra M, Kumar L, Agarwal VK, et al. Clinico-etiological evaluation of epistaxis. Indian J Otolaryngol Head Neck Surg. 2023;75(Suppl 1):828-35.
  10. Shaw CB, Wax MK. Epistaxis: a comparison of treatment. Otolaryngol Head Neck Surg. 1993;109(1):60-5.
  11. Juselius H. Epistaxis: a clinical study of 1,724 patients. J Laryngol Otol. 1974;88(4):317-27.
  12. Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ, Camargo CA, et al. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77-81.
  13. Tan LKS, Calhoun KH. Epistaxis. Med Clin North Am. 1999;83(1):43- 56.
  14. Musgrave KM, Powell J. A systematic review of anti-thrombotic therapy in epistaxis. Rhinology. 2016;54(4):292-301.
  15. Kitamura T, Murata T, Suzuki M, Nishimura T, Yamamoto A, Kobayashi K, et al. Sphenopalatine artery surgery for refractory idiopathic epistaxis: systematic review and meta-analysis. Laryngoscope. 2019;129(8):1731-6.
  16. Kumar S, Shetty A, Rockey J, Nilssen E. Contemporary surgical treatment of epistaxis: what is the evidence for sphenopalatine artery ligation? Clin Otolaryngol Allied Sci. 2003;28(4):360-3.
  17. Ors S, Ozkose M. Late postoperative massive bleeding in septorhinoplasty: a prospective study. Plast Surg. 2016;24(2):96.
  18. Joshi RR, Riley CA, Kacker A. Complication rates following septoplasty with inferior turbinate reduction. Ochsner J. 2019;19(4):353